LGM
PMVP icon

Logos Global Management’s PMV Pharmaceuticals PMVP Stock Holding History

Logos Global Management’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,400,000
Closed -$41.7M – 74
2021
Q3 		$41.7M Buy
1,400,000
+1,193,436
+578% +$38.1M 3.01% 11
2021
Q2 		$7.06M Buy
206,564
+6,564
+3% +$219K 0.59% 41
2021
Q1 		$6.58M Buy
200,000
+100,000
+100% +$3.94M 0.64% 29
2020
Q4 		$6.15M Sell
100,000
-50,000
-33% -$1.96M 0.53% 36
2020
Q3 		$5.33M Buy
+150,000
New +$5.52M 0.68% 28

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Logos Global Management's PMVP Position: Q4 2021 in Review

Logos Global Management sold out of PMV Pharmaceuticals (PMVP) in Q4 2021, closing a stake of 1,400,000 shares — an estimated $41.7M sold.

Logos Global Management first reported a position in PMVP in Q3 2020 and held it in 5 quarters. The position peaked at $41.7M in Q3 2021. 105 funds tracked by Wall St. Rank hold PMVP as of Q4 2021.

  • Logos Global Management reported no remaining PMV Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Logos Global Management sold 1,400,000 PMV Pharmaceuticals shares in Q4 2021, an estimated $41.7M.
  • Logos Global Management first reported a position in PMV Pharmaceuticals in Q3 2020 and held it in 5 quarters.
  • Logos Global Management's PMV Pharmaceuticals position peaked at $41.7M in Q3 2021.
  • 105 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q4 2021.

Based on Logos Global Management's 13F filing for Q4 2021, filed 14 Feb 2022.